Aerosol Formulations – Page 18

How to Conduct Life Cycle Assessments for Aerosol Products

A Life Cycle Assessment (LCA) is a systematic approach to evaluating the environmental impact of a product throughout its entire life cycle. For aerosol products, this includes raw material extraction,…

Addressing the Ozone Depletion Potential of Aerosol Components

Ozone Depletion Potential (ODP) measures the extent to which a chemical substance can damage the ozone layer. It is compared to a reference compound, typically chlorofluorocarbon-11 (CFC-11), which has an…

Implementing Zero-Waste Initiatives in Aerosol Production

Zero-waste initiatives aim to minimize waste generation by reusing, recycling, or repurposing materials at every stage of the production process. In aerosol production, this involves optimizing resources, reducing landfill waste,…

How to Develop Biodegradable Propellants for Aerosols

Biodegradable propellants are eco-friendly alternatives to traditional aerosol propellants, designed to break down naturally into non-toxic byproducts. These propellants aim to reduce the environmental impact of aerosols by minimizing pollution,…

Aerosol Spray Failures Like Poor Plume? Proven Formulation and Valve Solutions

Identifying the symptoms of aerosol spray failures is critical for timely intervention. Key indicators of potential formulation or delivery issues can include:Click to read the full article.

Leakage Failure during method transfer: FDA/MHRA inspection-ready documentation

Addressing Leakage Failure during Method Transfer in Pharmaceutical Manufacturing In pharmaceutical manufacturing, maintaining the integrity of dosage forms is crucial, particularly during method transfers from development to production. One common…

Propellant–Formulation Incompatibility during method transfer: device qualification and crimp validation controls

The first indicators of propellant-formulation incompatibility are often visible during preliminary testing phases. Common symptoms include:Click to read the full article.

Leakage Failure during method transfer: device qualification and crimp validation controls

Recognizing the symptoms of leakage failure is the first step in addressing this critical issue. Symptoms may include:Click to read the full article.

Particle Size Distribution Oos in MDI assembly: device qualification and crimp validation controls

Detection of OOS results for PSD typically surfaces as deviations reported during quality control testing of MDI products. Symptoms may include:Click to read the full article.

Canister Corrosion in MDI assembly: device qualification and crimp validation controls

The first step in addressing canister corrosion is recognizing the symptoms or signals that indicate potential issues. These may occur across various stages of production, from material receipt through to…

Valve Malfunction at stability pull: device qualification and crimp validation controls

Investigation into Valve Malfunction during Stability Pull Investigations In pharmaceutical manufacturing, a valve malfunction during stability pull poses significant challenges, particularly regarding product quality and compliance. Such incidents can lead…

Particle Size Distribution Oos during line setup: packaging integrity and transport risk assessment

Recognizing the symptoms and signals that indicate a particle size distribution OOS is the first step in addressing the issue. The following are key indicators that should prompt an investigation:Click…